|
Index of reports
> Cases resulting in other serious reactions (69)
> Cases with Confusional State (5)
Below is the selection of adverse event reports related to Altace (Ramipril) that includes cases resulting in other serious reactions where reactions include confusional state.
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Canada on 2007-07-30
Patient:
Adverse reactions / side effects: Confusional State, Hypoglycaemia, Hypoglycaemic Encephalopathy, Coma
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 1998-01-01
NPH Insulin
Dosage: 85 u, qd
Indication: Type 2 Diabetes Mellitus
Start date: 2001-05-29
Other drugs received by patient: Rhotral; Flovent; Novasen; Glyceryl Trinitrate; Pentoxifylline; Salvent; Zocor; Salbutamol; Acetylcysteine
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Canada on 2007-07-10
Patient:
Adverse reactions / side effects: Confusional State, Hypoglycaemia, Hypoglycaemic Encephalopathy, Coma
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 1998-01-01
NPH Insulin
Dosage: 85 u, qd
Indication: Type 2 Diabetes Mellitus
Start date: 2001-05-29
Other drugs received by patient: Rhotral; Flovent; Novasen; Glyceryl Trinitrate; Pentoxifylline; Salvent; Zocor; Salbutamol; Acetylcysteine
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-03-16
Patient:
Adverse reactions / side effects: Anxiety, Confusional State, Panic Reaction
Suspect drug(s):
Altace (Ramipril)
Other drugs received by patient: Bendroflumethiazide
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-03-15
Patient:
Adverse reactions / side effects: Confusional State, Hypoglycaemia, Hypoglycaemic Encephalopathy, Coma
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 1998-01-01
NPH Insulin
Dosage: 85 u, qd
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2001-05-29
Other drugs received by patient: Rhotral; Flovent; Novasen; Glyceryl Trinitrate; Pentoxifylline; Salvent; Zocor; Salbutamol; Acetylcysteine
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United Kingdom on 2007-02-07
Patient:
Adverse reactions / side effects: Confusional State, Dermatitis Bullous, Mobility Decreased
Suspect drug(s):
Altace (Ramipril)
Other drugs received by patient: Amiodarone HCL; Calcichew D3; Cyclizine; Fentanyl; Folic Acid; Frusemide; Gluconate ION; Mebeverine; Movicol; Prednisolone; Pantoprazole Sodium; Spironolactone; Warfarin Sodium
|
